Drug manufacturer Merck sent letters to 340B covered entities by email on Tuesday to provide background and answer questions about its request that entities voluntarily upload their contract pharmacy claims to a vendor’s software platform so they can be checked for 340B discounts and Medicaid, Medicare Part D, and commercial rebates on the same Merck drugs.
Merck is one of several manufacturers that have acted in recent months to stem financial losses due to 340B contract pharmacy. Unlike some, Merck has not stopped offering 340B pricing on drugs shipped to multiple contract pharmacies, or conditioned such 340B pricing on entities’ provision of their claims data. Likely as a result, there are no reports that it is being sued, or is suing anyone, over 340B contract pharmacy.
Drug manufacturer Merck sent letters to 340B covered entities by email on Tuesday to provide background and answer questions about its request that entities voluntarily upload their contract pharmacy claims to a vendor’s software platform so they can be checked for 340B discounts and Medicaid, Medicare Part D, and commercial rebates on the same Merck drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
